Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


July 05, 2015 11:36 AM ET

Healthcare Equipment and Supplies

Company Overview of ReVision Optics, Inc.

Company Overview

ReVision Optics, Inc. develops and commercializes optical solutions for the treatment of presbyopia in the United States. It offers Raindrop Near Vision Corneal Inlay, a refractive surgery solution that improves the near vision that has been lost by the eye’s natural aging process. The company was formerly known as IntraLens Vision, Inc. and changed its name to ReVision Optics, Inc. in October 2005. ReVision Optics, Inc. was founded in 1996 and is based in Lake Forest, California.

25651 Atlantic Ocean Drive

Suite A1

Lake Forest, CA 92630-8835

United States

Founded in 1996

Phone:

949-707-2740

Fax:

949-707-2744

Key Executives for ReVision Optics, Inc.

Chief Executive Officer, President and Director
Age: 55
Co-Founder
Age: 71
Chief Financial Officer
Chief Compliance Officer and Vice President of Regulatory Affairs & Quality Assurance
Age: 54
Vice President of Research & Development
Compensation as of Fiscal Year 2015.

ReVision Optics, Inc. Key Developments

NovaMedika Enters into Collaboration Agreement with ReVision Optics

NovaMedika has entered an agreement with ReVision Optics for the latter's Raindrop Near Vision Corneal Inlay technology. Under the terms of the agreement, NovaMedika gains exclusive rights to commercialize products developed with that technology in Russia and the Commonwealth of Independent States. The technology is in late Phase III trials and is being developed for the correction of vision in patients with presbyopia and refraction anomalies by inserting a hydrogel insert under the cornea of the eye. The agreement reportedly involves both therapeutic 'substances' and medical equipment, and is important for NovaMedika as it tries to emerge as a player in originator innovative technologies in a market where most domestic companies are focused on generics.

Similar Private Companies By Industry

Company Name Region
Applied Nutritionals, LLC United States
Thuasne North America, Inc. United States
Paragon 28, Inc. United States
Permobil, Inc. United States
Symmetry Medical USA, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ReVision Optics, Inc., please visit revisionoptics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.